Personalized medicine and disruptive innovation: implications for technology assessment.
Schulman
Kevin A
KA
Duke Clinical Research Institute, Duke Translational Medicine Institute, Durham, North Carolina, USA. kevin.schulman@duke.edu
Vidal
Ana Valverde
AV
Ackerly
D Clay
DC
D003695:Delivery of Health Care / Q000379:methods / Q000639:trends; D004059:Diffusion of Innovation; D006801:Humans; D033181:Information Dissemination / Q000379:methods*; D010548:Personal Health Services / Q000379:methods*; D013673:Technology Assessment, Biomedical / Q000379:methods